🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Three hepatology masters receiving western hospitality. I see them ready for next year Stampede. ⁦Ian Rowe⁩ ⁦Jennifer Flemming⁩ ⁦@NDP1001⁩

Dogs with elevated ALT are unlikely to die from liver disease And a normal ALT does not exclude liver disease What’s true for our dogs is also true for us

#BASL2024 is few days away don’t forget to register and join us in Harrogate basl.org.uk

Hey #livertwitter Talking this week at #BASL2024 - research studies round up What are your top 3 research studies in the last 12 months? What has changed your practice? EASL Education AASLD BASL education feed

Could you help us prevent relapse to alcohol for patients with advanced liver disease? If you work in this area or are a patient or caregiver, please consider sharing your views by completing our short survey. thiscovery.org/preventing-rel…

Fantastic BASL annual meeting 🙌🏼 BASL end of life SIG meeting upcoming: 7th November 2024 Birmingham Multiprofessional Free attendance Hybrid Contact [email protected] REDUCe2 EVOLVE Cathy Beresford #palliativehepatology #ESLD #EOLC Programme 👇🏼

Had to be done and we are proud Hepatology Communications brings the first concordance of MASLD and NAFLD study in pediatrics journals.lww.com/hepcomm/fullte… Ian Rowe

Congratulations Ian Rowe for this excellent methodological review of HCC risk models, which I will use for my next HCC risk model 😉 & reach out to you and Hamish Innes for some validation data! See next for thoughts on using Competing Risk models

You are invited to play HepMadness Brought to you by Liver Fellow Network Fill out a bracket: tourneytopia.com/aasld/hepmadne… Pick your winners amongst the hottest topics in all of liverland and, maybe, win a prize Inspired by work published in Liver Transplantation Journal (LTxJournal) and Hepatology Communications

Interesting morning promoting organ transplantation! I will never tire of seeing the impact transplant has on recipients and their families and am privileged to be able to play a small part in the process Leeds Teaching Hospitals NHS Blood+Transplant Leeds Liver Transplant and Hepatology

This should be a fun discussion - there is no perfect scheme for allocation of livers... Lots of issues to talk about! BASL education feed NHSBT Statistics British Liver Trust

🔥 Off the press New data on Steatotic Liver Disease Journal of Clinical and Experimental Hepatology Highlighting the effects of 🍷on outcomes Check out 👇🏽 jcehepatology.com/article/S0973-… Dr Nipun Verma Juan Pablo (JP) Arab, MD  Rohit Loomba Ajay Duseja Anand V Kulkarni M PREMKUMAR Dr Ashish Kumar Liver Fellow Network Elliot Tapper Maja Thiele

So much to say on #ESSENCE Placebo response = sampling variability, see cghjournal.org/article/S1542-… Also, improvements in steatosis at least are mediated through weight loss, see jhep-reports.eu/article/S2589-… Elliot Tapper

Important data in #MASH but probably not the game changer some think 75% of patients had a potential indication for SEMA, BMI>30 or T2DM GLP1RA is a foundational treatment for patients with metabolic multimorbidity If initiated for those reasons, MASH indication not needed

This was very much a team effort! The heavy lifting was done by Katrina from Leeds Institute of Medical Research Post-grads and Richard Parker Much value in reproducing work in this context, highlighting the role of #alcohol in driving liver disease Leeds Teaching Hospitals

Looking forward to catching up with friends and colleagues EASL Education But first, cycling for liver health and sustainability. Stage 1 complete, next stage Rotterdam to Amsterdam tomorrow! #EASLCongress

We've made it to Amsterdam, fresh and ready for EASL Education #EASLCongress Happy to support raising awareness of liver health and disease British Liver Trust Leeds Teaching Hospitals

#EASLStudio live from #EASLcongress will be back tomorrow morning with another great lineup! 🤩 As usual you can tune in online 💻easl.eu/studio-at-easl… or attend on site in the Hepatology Arena. @EASLNews #LiverX

Really looking forward to these conversations, lots of unresolved issues and questions to be answered Come along and hear what we still need to understand #EASLCongress

Privileged to be part of this wide-ranging discussion #EASLStudio at the #EASLCongress We explored lots of the important issues around screening for liver disease and why it is critical that we build the evidence base to support it Free to watch back, it's worth the time!